|
Post by itellthefuture777 on Aug 7, 2020 16:46:24 GMT -5
|
|
|
Post by awesomo on Aug 7, 2020 16:50:52 GMT -5
Castagna fans: "We're in the clear financially for at least awhile based on the call!" Mike (two days later): "So yeah, I'm gonna go fund raise again..."
|
|
|
Post by itellthefuture777 on Aug 7, 2020 16:54:49 GMT -5
Castagna fans: "We're in the clear financially for at least awhile based on the call!" Mike (two days later): "So yeah, I'm gonna go fund raise again..." SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Aug. 5, 2020 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that Dr. Martine Rothblatt, Chairman and Chief Executive Officer of United Therapeutics, will provide an overview and update on the company's business during a fireside chat session at the Wedbush PacGrow Healthcare Virtual Conference. The presentation will take place on Tuesday, August 11, 2020, from 8:00 to 8:30 a.m., Eastern Daylight Time, and can be accessed via a live webcast on the United Therapeutics website at ir.unither.com/events-and-presentations. An archived, recorded version of the presentation will be available approximately 24 hours after the session ends and can be accessed at the same location for 90 days. United Therapeutics 8-8:30 and then another conference the same day Mannkind at 2pm hmm What we know for a fact is Mannkind never talks about anything United Therapeutics/Mannkind related..before United Therapeutics talks about it...hmmm
|
|
|
Post by Clement on Aug 8, 2020 7:19:59 GMT -5
United Therapeutics 8:00 to 8:30 am --- conveniently before the market opens that day
|
|
|
Post by sayhey24 on Aug 8, 2020 7:29:31 GMT -5
Castagna fans: "We're in the clear financially for at least awhile based on the call!" Mike (two days later): "So yeah, I'm gonna go fund raise again..." If Mike can get line up cheap money when he does not need it, that sounds like a good idea to me. He can then decide on pulling the trigger. You can never have enough money and as Al Mann said, the top three things you need in getting a product into the market are money, money and money. At this point MNKD does not have the top three things.
|
|
|
Post by rfogel on Aug 8, 2020 7:57:15 GMT -5
United Therapeutics 8:00 to 8:30 am --- conveniently before the market opens that day Who listens to "fireside chats" at 8 in the morning?
|
|
|
Post by boytroy88 on Aug 11, 2020 7:49:32 GMT -5
Did anyone listen to the UTHR fire chat?
|
|
|
Post by cppoly on Aug 11, 2020 8:04:11 GMT -5
I briefly caught it. Mannkind was discussed as a very good partner. Breeze study was discussed. They are fully expecting approval in 2021.
|
|
|
Post by nemzter on Aug 11, 2020 8:45:21 GMT -5
|
|
|
Post by Clement on Aug 11, 2020 9:03:06 GMT -5
I briefly caught it. Mannkind was discussed as a very good partner. Breeze study was discussed. They are fully expecting approval in 2021. Martine said she expects TreT "will be approved and launched in 2021".
|
|
|
Post by MnkdWASmyRtrmntPlan on Aug 11, 2020 9:59:19 GMT -5
Yeah, that's so true, Nemzter. Martine would be a fantastic CEO of Mannkind. But, the UT buyout/buyin dream is still out there. Hey, ya never know. See, it's the potential things like that and way-overdue RLS announcements, etc., etc., that could send our stock price up multiple times in a heartbeat that are the reason why I cannot get myself to sell.
|
|
|
Post by cjm18 on Aug 11, 2020 10:13:56 GMT -5
I briefly caught it. Mannkind was discussed as a very good partner. Breeze study was discussed. They are fully expecting approval in 2021. Martine said she expects TreT "will be approved and launched in 2021". This jives with mnkd saying on earnings call they plan to file in q1.
|
|
|
Post by mytakeonit on Aug 11, 2020 13:21:05 GMT -5
And that's why I want to buy more shares for my daughter's account. Oh, I already did. Sorry, you know how dementia works. But, that's mytakeonit
|
|
|
Post by nylefty on Aug 11, 2020 14:32:31 GMT -5
|
|
|
Post by neil36 on Aug 11, 2020 15:00:22 GMT -5
Interesting that he says there are currently 3,000 script-writers for Afrezza. His goal is to get that to 4,000, each writing five scripts a week.
Doing the math on that would mean that the current 3,000 are averaging less than one prescription per month (750 per week). I found it at least mildly interesting that their sales goal is less about getting new endos, and more about getting endos who currently have someone on Afrezza to put more patients on it.
|
|